MyoD


MyoD
Myogenic differentiation 1

PDB rendering based on 1mdy.
Identifiers
Symbols MYOD1; MYF3; MYOD; PUM; bHLHc1
External IDs OMIM159970 MGI97275 HomoloGene7857 GeneCards: MYOD1 Gene
RNA expression pattern
PBB GE MYOD1 206657 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 4654 17927
Ensembl ENSG00000129152 ENSMUSG00000009471
UniProt P15172 Q8C6B1
RefSeq (mRNA) NM_002478.4 NM_010866.2
RefSeq (protein) NP_002469.2 NP_034996.2
Location (UCSC) Chr 11:
17.74 – 17.74 Mb
Chr 7:
53.63 – 53.63 Mb
PubMed search [1] [2]

MyoD is a protein with a key role in regulating muscle differentiation. MyoD belongs to a family of proteins known as myogenic regulatory factors (MRFs).[1] These bHLH (basic helix loop helix) transcription factors act sequentially in myogenic differentiation. MRF family members include MyoD, Myf5, myogenin, and MRF4 (Myf6).

MyoD is one of the earliest markers of myogenic commitment. MyoD is expressed in activated satellite cells, but not in quiescent satellite cells. Although MyoD marks myoblast commitment, muscle development is not dramatically ablated in mouse mutants lacking the MyoD gene. This is likely to be due to functional redundancy from Myf5.

Contents

Functions of MyoD

The function of MyoD in development is to commit mesoderm cells to a skeletal lineage, and then to regulate that process. MyoD may also play a role in regulating muscle repair. MyoD mRNA levels are also reported to be elevated in aging skeletal muscle.

One of the main actions of MyoD is to remove cells from the cell cycle (halt proliferation) by enhancing the transcription of p21. MyoD is inhibited by cyclin dependent kinases (CDKs). CDKs are in turn inhibited by p21. Thus MyoD enhances its own activity in the cell.

Interactions

MyoD has been shown to interact with HDAC1,[2][3] ID1,[4][5][6][7][8][9] ID2,[5] Retinoblastoma protein,[3][10] STAT3,[11] CSRP3,[12] Cyclin-dependent kinase 4,[13][14] CREB-binding protein,[15][16] TCF3,[5][17] MOS,[18] EP300,[16][19] C-jun,[20] Cyclin-dependent kinase inhibitor 1C,[21] Retinoid X receptor alpha[22] and MDFI.[23]

Coactivators of MyoD

IFRD1 is a positive cofactor of MyoD, as it cooperates with MyoD at inducing the transcriptional activity of MEF2C (by displacing HDAC4 from MEF2C); moreover IFRD1 also represses the transcriptional activity of NF-kB, which is known to inhibit MyoD mRNA accumulation.[24][25]

References

  1. ^ "Entrez Gene: MYOD1 myogenic differentiation 1". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4654. 
  2. ^ Puri, P L; Iezzi S, Stiegler P, Chen T T, Schiltz R L, Muscat G E, Giordano A, Kedes L, Wang J Y, Sartorelli V (Oct. 2001). "Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis". Mol. Cell (United States) 8 (4): 885–97. doi:10.1016/S1097-2765(01)00373-2. ISSN 1097-2765. PMID 11684023. 
  3. ^ a b Mal, A; Sturniolo M, Schiltz R L, Ghosh M K, Harter M L (Apr. 2001). "A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program". EMBO J. (England) 20 (7): 1739–53. doi:10.1093/emboj/20.7.1739. ISSN 0261-4189. PMC 145490. PMID 11285237. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=145490. 
  4. ^ Garkavtsev, Igor; Kozin Sergey V, Chernova Olga, Xu Lei, Winkler Frank, Brown Edward, Barnett Gene H, Jain Rakesh K (Mar. 2004). "The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis". Nature (England) 428 (6980): 328–32. doi:10.1038/nature02329. PMID 15029197. 
  5. ^ a b c Langlands, K; Yin X, Anand G, Prochownik E V (Aug. 1997). "Differential interactions of Id proteins with basic-helix-loop-helix transcription factors". J. Biol. Chem. (UNITED STATES) 272 (32): 19785–93. doi:10.1074/jbc.272.32.19785. ISSN 0021-9258. PMID 9242638. 
  6. ^ Finkel, T; Duc J, Fearon E R, Dang C V, Tomaselli G F (Jan. 1993). "Detection and modulation in vivo of helix-loop-helix protein-protein interactions". J. Biol. Chem. (UNITED STATES) 268 (1): 5–8. ISSN 0021-9258. PMID 8380166. 
  7. ^ Gupta, K; Anand G, Yin X, Grove L, Prochownik E V (Mar. 1998). "Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc". Oncogene (ENGLAND) 16 (9): 1149–59. doi:10.1038/sj.onc.1201634. ISSN 0950-9232. PMID 9528857. 
  8. ^ McLoughlin, Patricia; Ehler Elisabeth, Carlile Graeme, Licht Jonathan D, Schäfer Beat W (Oct. 2002). "The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein". J. Biol. Chem. (United States) 277 (40): 37045–53. doi:10.1074/jbc.M203336200. ISSN 0021-9258. PMID 12145280. 
  9. ^ Ling, Ming-Tat; Chiu Yung-Tuen, Lee Terence Kin Wah, Leung Steve Chin Lung, Fung Maggie Ka Lai, Wang Xianghong, Wong Kwong Fai, Wong Yong-Chuan (Sep. 2008). "Id-1 induces proteasome-dependent degradation of the HBX protein". J. Mol. Biol. (England) 382 (1): 34–43. doi:10.1016/j.jmb.2007.06.020. PMID 18674781. 
  10. ^ Gu, W; Schneider J W, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B (Feb. 1993). "Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation". Cell (UNITED STATES) 72 (3): 309–24. doi:10.1016/0092-8674(93)90110-C. ISSN 0092-8674. PMID 8381715. 
  11. ^ Kataoka, Yoshihisa; Matsumura Itaru, Ezoe Sachiko, Nakata Soichi, Takigawa Eri, Sato Yusuke, Kawasaki Akira, Yokota Takashi, Nakajima Koichi, Felsani Armando, Kanakura Yuzuru (Nov. 2003). "Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts". J. Biol. Chem. (United States) 278 (45): 44178–87. doi:10.1074/jbc.M304884200. ISSN 0021-9258. PMID 12947115. 
  12. ^ Kong, Y; Flick M J, Kudla A J, Konieczny S F (Aug. 1997). "Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD". Mol. Cell. Biol. (UNITED STATES) 17 (8): 4750–60. ISSN 0270-7306. PMC 232327. PMID 9234731. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=232327. 
  13. ^ Zhang, J M; Zhao X, Wei Q, Paterson B M (Dec. 1999). "Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation". EMBO J. (ENGLAND) 18 (24): 6983–93. doi:10.1093/emboj/18.24.6983. ISSN 0261-4189. PMC 1171761. PMID 10601020. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1171761. 
  14. ^ Zhang, J M; Wei Q, Zhao X, Paterson B M (Feb. 1999). "Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4". EMBO J. (ENGLAND) 18 (4): 926–33. doi:10.1093/emboj/18.4.926. ISSN 0261-4189. PMC 1171185. PMID 10022835. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1171185. 
  15. ^ Polesskaya, A; Naguibneva I, Duquet A, Bengal E, Robin P, Harel-Bellan A (Aug. 2001). "Interaction between acetylated MyoD and the bromodomain of CBP and/or p300". Mol. Cell. Biol. (United States) 21 (16): 5312–20. doi:10.1128/MCB.21.16.5312-5320.2001. ISSN 0270-7306. PMC 87255. PMID 11463815. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=87255. 
  16. ^ a b Sartorelli, V; Huang J, Hamamori Y, Kedes L (Feb. 1997). "Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C". Mol. Cell. Biol. (UNITED STATES) 17 (2): 1010–26. ISSN 0270-7306. PMC 231826. PMID 9001254. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=231826. 
  17. ^ Maleki, S J; Royer C A, Hurlburt B K (Jun. 1997). "MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable". Biochemistry (UNITED STATES) 36 (22): 6762–7. doi:10.1021/bi970262m. ISSN 0006-2960. PMID 9184158. 
  18. ^ Lenormand, J L; Benayoun B, Guillier M, Vandromme M, Leibovitch M P, Leibovitch S A (Feb. 1997). "Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins". Mol. Cell. Biol. (UNITED STATES) 17 (2): 584–93. ISSN 0270-7306. PMC 231783. PMID 9001211. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=231783. 
  19. ^ Lau, P; Bailey P, Dowhan D H, Muscat G E (Jan. 1999). "Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD". Nucleic Acids Res. (ENGLAND) 27 (2): 411–20. doi:10.1093/nar/27.2.411. ISSN 0305-1048. PMC 148194. PMID 9862959. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=148194. 
  20. ^ Bengal, E; Ransone L, Scharfmann R, Dwarki V J, Tapscott S J, Weintraub H, Verma I M (Feb. 1992). "Functional antagonism between c-Jun and MyoD proteins: a direct physical association". Cell (UNITED STATES) 68 (3): 507–19. doi:10.1016/0092-8674(92)90187-H. ISSN 0092-8674. PMID 1310896. 
  21. ^ Reynaud, E G; Leibovitch M P, Tintignac L A, Pelpel K, Guillier M, Leibovitch S A (Jun. 2000). "Stabilization of MyoD by direct binding to p57(Kip2)". J. Biol. Chem. (UNITED STATES) 275 (25): 18767–76. doi:10.1074/jbc.M907412199. ISSN 0021-9258. PMID 10764802. 
  22. ^ Froeschlé, A; Alric S, Kitzmann M, Carnac G, Auradé F, Rochette-Egly C, Bonnieu A (Jul. 1998). "Retinoic acid receptors and muscle b-HLH proteins: partners in retinoid-induced myogenesis". Oncogene (ENGLAND) 16 (26): 3369–78. doi:10.1038/sj.onc.1201894. ISSN 0950-9232. PMID 9692544. 
  23. ^ Chen, C M; Kraut N, Groudine M, Weintraub H (Sep. 1996). "I-mf, a novel myogenic repressor, interacts with members of the MyoD family". Cell (UNITED STATES) 86 (5): 731–41. doi:10.1016/S0092-8674(00)80148-8. ISSN 0092-8674. PMID 8797820. 
  24. ^ Micheli L, Leonardi L, Conti F, Buanne P, Canu N, Caruso M, Tirone F (March 2005). "PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C". Mol. Cell. Biol. 25 (6): 2242–59. doi:10.1128/MCB.25.6.2242-2259.2005. PMC 1061592. PMID 15743821. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1061592. 
  25. ^ Micheli L, Leonardi L, Conti F, Maresca G, Colazingari S, Mattei E, Lira SA, Farioli-Vecchioli S, Caruso M, Tirone F (February 2011). "PC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaB". J. Biol. Chem. 286 (7): 5691–707. doi:10.1074/jbc.M110.162842. PMC 3037682. PMID 21127072. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3037682. 

Further reading

External links


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • MyoD — Proteína 1 de diferenciación miogénica Estructura tridimensional de la proteína MyoD. HUGO …   Wikipedia Español

  • myoD — (= MyoD1) MyoD (myogenic determination) was originally described as a master regulatory gene for the determination of muscle cells, a process now thought to involve a family of genes. It is normally only expressed in myoblasts and skeletal muscle …   Dictionary of molecular biology

  • MyoD — En biologie, MyoD est une protéine, un facteur de transcription ayant un rôle clé dans la détermination et la différentiation des cellules musculaires striées. Il fait partie des MRF[1], les facteurs de transcription myogéniques. Action de MyoD… …   Wikipédia en Français

  • MDFI — MyoD family inhibitor, also known as MDFI, is a human gene.cite web | title = Entrez Gene: MDFI MyoD family inhibitor| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene Cmd=ShowDetailView TermToSearch=4188| accessdate = ] PBB Summary section …   Wikipedia

  • Myogener Faktor 3 — Masse/Länge Primärstruktur 320 Aminosäuren …   Deutsch Wikipedia

  • Myogenin — (myogenic factor 4) Identifiers Symbols MYOG; MYF4; MYOGENIN; bHLHc3 External IDs …   Wikipedia

  • EP300 — See also: p300 CBP coactivator family E1A binding protein p300 PDB rendering based on 1f81 …   Wikipedia

  • Proteína del retinoblastoma — Retinoblastoma 1 (including osteosarcoma) HUGO 9884 Símbolo RB1 Símbolos alt. OSRC …   Wikipedia Español

  • CREB-binding protein — See also: p300 CBP coactivator family CREB binding protein PDB rendering based on 1f81 …   Wikipedia

  • NF-κB — Mechanism of NF κB action. In this figure, the NF κB heterodimer between Rel and p50 proteins is used as an example. While in an inactivated state, NF κB is located in the cytosol complexed with the inhibitory protein IκBα. Through the… …   Wikipedia


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.